Please note that the details of this Challenge are no longer open. This challenge is withdrawn and is no longer accepting new submissions. You can:
Challenge Alternatives to Live Vaccines
Alternatives to Live Vaccines
Award:  $20,000 USD
Deadline: Withdrawn
Active Solvers: 250
Posted: Sep 01 2016
Challenge ID: 9933912
 
Team Project Rooms are available on this Challenge. Team Share Challenge Share
Abstract

Vaccination is a safe and effective way of gaining protection from preventable diseases. In order to elicit a natural immune response, some vaccines are prepared with live organisms. However, live vaccines are not recommended when the immune system is weakened or compromised. Therefore, the Seeker is searching for viable alternatives to live vaccines.

This Theoretical Challenge requires only a written proposal.

Overview

Live vaccines may consist of virulent (unattenuated) or weakened (attenuated) strains of a particular pathogen. The advantage of an attenuated vaccine is that it elicits a strong immune response with little danger of causing disease. Although unlikely, the attenuated strain could mutate and become pathogenic. Furthermore, propagation of these vaccines in animals poses a significant animal welfare issue. For these reasons, the Seeker is searching for viable alternatives to live vaccines.

This is a Theoretical Challenge that requires only a written proposal to be submitted. The Challenge award will be contingent upon theoretical evaluation of the proposal by the Seeker.

To receive an award, the Solvers will not have to transfer their exclusive IP rights to the Seeker. Instead, Solvers will grant to the Seeker a non-exclusive license to practice their solutions. 

Submissions to this Challenge must be received by 11:59 PM (US Eastern Time) on October 31, 2016. 

Late submissions will not be considered.

What is InnoCentive?
InnoCentive is the global innovation marketplace where creative minds solve some of the world's most important problems for cash awards up to $1 million. Commercial, governmental and humanitarian organizations engage with InnoCentive to solve problems that can impact humankind in areas ranging from the environment to medical advancements.

What is a Theoretical-Licensing Challenge?

An InnoCentive Theoretical Challenge builds upon an idea but is not yet a proof of concept. A solution to a Theoretical Challenge will solidify the Solver's concept with detailed descriptions, specifications and requirements necessary to bringing a good idea closer to becoming an actual product or service.

This Challenge is a Theoretical-Licensing Challenge, meaning that the Seeker is requesting non-exclusive rights to use the winning solution. By contrast, Theoretical-IP Transfer means that Solvers must relinquish all rights to the Intellectual Property (IP) for which they are awarded. For these forms of a Theoretical Challenge, Solvers that do not win retain the rights to their solution after the evaluation period is complete. The Seeker retains no rights to any IP not awarded.

Share This Challenge
InnoCentive Trust Partners